Related Experiment Video
Updated: Mar 20, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Initial experience with ocriplasmin in the treatment of vitreomacular traction
José Maurício Botto de Barros Garcia1, David Leonardo Cruvinel Isaac1, Marcos Ávila1
1Ophthalmology Department, Centro de Referência em Oftalmologia, Goiânia, GO, Brazil.
Abstract:
This study aimed to report the clinical and structural outcomes of intravitreal ocriplasmin in the treatment of vitreomacular interface disorders in two tertiary centers in Brazil. A retrospective study was performed by reviewing medical records and spectral domain optical coherence tomography (SD-OCT) findings of seven patients who were treated with a single ocriplasmin injection. A total of 57.14% of patients achieved resolution of vitreomacular traction as evidenced by SD-OCT. Regarding our functional results, 87.71% maintained or improved visual acuity after follow-up. To the best of our knowledge, this is the first study reporting initial results of ocriplasmin therapy in Brazil.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Venous Thrombosis III: Interprofessional Care
Clot Retraction and Fibrinolysis

